All News

#ACR22 Abs 1752 finds rates of incident cancer did not differ between patients treated with anti-TNF and other bDMARDs or tsDMARDs. @RheumNow https://t.co/ycnQzrmAjw https://t.co/CSgDq2Gazg

Cancer Risk in Patients with Rheumatic Diseases Exposed to Different Biologic a…

Abs 1757 at #ACR22 finds women w/ gout have a higher risk of all-cause mortality, which is primarily driven by higher risk of CVD deaths. @RheumNow https://t.co/kPDL2VYRCN https://t.co/9qARr7T4fI

The Independent Impact of Gout on Mortality and Risk of Coronary Heart Disease …

Abs L04 reviews novel humanized murine model of PsA disease phenotypes mediated by CD8 T Cells. Perhaps this is a step forward in personalized medicine. #ACR22 @RheumNow https://t.co/fPoElqFLI7 https://t.co/4pxBKoPnym

Psoriatic Arthritis Disease Subtypes Mediated by CD8 T Cells Are Phenocopied in…

Prof Petri presents mortality data of their #lupus cohort 🔅55 yrs - ave age of death from all causes Top 4 common causes of death: 🔅SLE 🔅CVD 🔅Cancer 🔅Infection African-americans had ⬆️proportions of death from infections & renal causes #ACR22 @RheumNow #ABST2068 https://t.co/B5cAfZiRJp

Is sustained B cell depletion assoc w/⬇️dse flares in #lupus nephritis? In this study by Dr D Zisa, pts treated w/ BCA & had sustained Bcell depletion = ⬇️dse flares 👉Rapid repletion to BCC>100c/uL was assocd w/ 15.2x risk for flares #ACR22 @RheumNow ABST2065 https://t.co/ivSjm98YvZ

Is there a difference between IL-17i and TNFi in preventing radiographic progression in radiographic axSpA? Head to head study secukinumab vs. adalimumab biosimilar shows no sig difference with low radiographic progression. #ACRBest Abs#L15 @RheumNow #ACR22 https://t.co/UiHMtakaPz

Clinical pearl! Abs 1790 at #ACR22 finds bilateral US assessment of knees, wrists and hips provided the best sensitivity and specificity for diagnosing CPPD. @RheumNow https://t.co/3zlrNGCek4 https://t.co/hPK3eMH6iY

Ultrasound Diagnosis of Calcium Pyrophosphate Crystal Deposition: Which Sites S…

Are we screening & tx approp. for HBV in #IIM? Abstr #1864 found: - 78% IIM pts were screened for HBV (mean time 21 months from time of dx) - 73% Hep B Core Ab+ on RTX received Ppx tx - IIM pts Hep B Core Ab+ ↑ % +myositis spec ab and reach remission w/ IVIG @RheumNow #ACR22 https://t.co/QlQxGlkIhh

Denosumab for erosive hand OA? Abs L05 shows less erosive progression at week 24 with enhancement, including pain symptom improvement, at week 48. I can't wait to see more on this! #ACRbest #ACR22 @RheumNow https://t.co/aYb1biVgqt https://t.co/xHXj7nu1IJ

Effect of Denosumab on Structure Modification in Erosive Hand Osteoarthritis: R…

Uric acid appears to be negatively associated with bone mineral density in premenopausal but not in postmenopausal women with RA in Abs 1826 #ACR22 @RheumNow https://t.co/Cus73EeMDP https://t.co/e6mrEw4mR4

Association of High Uric Acid Levels with Low Bone Mineral Density in Pre- but …

#lupus pts w/ SKIN involvement had lower HRQoL by SF-36 than those w/o skin involvement as reported by Dr Alician Van from their study. Significance?⬆️ awareness so we can improve coping strategies & support for these pts. #ACR22 @RheumNow ABST#2089 @rheumarhyme @doktora_ging https://t.co/BKKl8BCN9y

Are we seeing ↑ MDA-5 associated DM post-COVID? Abstr #1857 found since start of pandemic - ↑ in % of myositis specific ab testing - ↑ +MDA-5 since onset of pandemic Conclusion: It is possible but we need more data (n = and longitudinal f/u) @RheumNow #ACR22 https://t.co/ZdfDdFc2hZ

#Abst1669 #ACR22 @RheumNow retrospective study of pts w/checkpoint inhibitor associated arthritis: Rx w/ TNFi ± MTX or IL6Ri ± MTX assoctd w/shorter time to cancer progression but faster arthritis control vs pts treated w/MTX alone. optimal approach yet to be identified #ACRBest https://t.co/lyR2C6zR80

Be wary in the post-Roe v Wade world 1 in 17 pts who tried to fill MTX experienced unexpected barriers Most issues with pharmacy seeking to confirm purpose of Rx - doctors should include dx on prescription! #ACRBest Abs#L09 @RheumNow #ACR22 https://t.co/WOWCfOPWUk

FMF should be considered in people with short-lived and red mono-oligoarthritis in the large joints of the lower extremities. Abs 1830 #ACR22 @RheumNow https://t.co/86AJkhd0br https://t.co/KuWuTDhgwj

Characteristics of Arthritis in Familial Mediterranean Fever Patients - ACR Mee…

Canakinumab provides a significant reduction in disease severity, attack frequency, and acute phase reactant levels in FMF. Abs 1834 #ACR22 @RheumNow https://t.co/3JYDi7eaBU https://t.co/NepMkQniiB

Canakinumab Treatment in Familial Mediterranean Fever Patients with Colchicine …

ORAL Surveillance update! Composite ischemic CV/HF risk not numerically different w/ tofa vs TNFi. In pts w/ ASCVD hx, MACE endpoints were numerically higher w/ tofa. CV risk was higher w/ tofa 10 mg BID vs TNFi. Check out CIs! Abs L06 #ACR22 @RheumNow https://t.co/XXTsU4el66 https://t.co/WvFqziKVkT

Risk of Extended Major Adverse Cardiovascular Event Endpoints with Tofacitinib …

Is there ↑ delay in #Dermatomyositis dx and tx by race? Abstr #1861 showed: Median # of days from Dx → Tx by race: - White: 4 days - Hispanic: 14 days - Black: 21 Whites vs other races: 4 vs 14 days @RheumNow #ACR22 https://t.co/wWgfgtRHa5

#ACR22 Abstr#0996 After #Lupus target is met (LLDAS/DORIS Clinical/Complete Remission), is it safe to further taper steroid/ immunosuppressant? A study in Asia-Pacific reported in stable SLE, tapering increased flares. Best done in sustained complete remission state @RheumNow https://t.co/oa1Os6bARk

IgG4 RD study Abs 1840 at #ACR22 finds “Retroperitoneum and Aorta” and “Head and Neck-Limited” phenotypes more difficult than expected to capture w/ 2019 ACR/EULAR criteria. @RheumNow https://t.co/y045bTWVmC https://t.co/bA8MMiN7hT

The 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease Perform Low…

Topics

All News

Do you get our email newsletter?